International Journal For Multidisciplinary Research

E-ISSN: 2582-2160   •   Impact Factor: 9.24

A Widely Indexed Open Access Peer Reviewed Multidisciplinary Bi-monthly Scholarly International Journal

Call for Paper Volume 7, Issue 1 (January-February 2025) Submit your research before last 3 days of February to publish your research paper in the issue of January-February.
Submit Research Paper Join as a Reviewer

Plagiarism is checked by the leading plagiarism checker TurnItIn

Call for Paper

Volume 7 Issue 1
January-February 2025

Submit your research paper

Indexing Partners
Academia Advanced Sciences Index Bielefeld Academic Search Engine CiteSeer DRJI Google Scholar Independent Search Engine & Directory Network ISI (International Scientific Indexing) Issuu Mendeley Research Networks
RefSeek ResearcherId - Thomson Reuters ResearchGate Scirus Scribd Semantic Scholar UTeM - Universiti Teknikal Malaysia Melaka Wiki for Call for Papers WorldCat Zenodo

Role of Pharmacovigilance Programme of India (PvPI) in Adverse Drug Event Monitoring for medication safety in patient

Author(s) Aarti, Sanjay Kumar Singh, Mithilesh Kumar
Country India
Abstract A pharmacovigilance system is a specialized domain within the pharmacological sciences that pertains to the reporting of Adverse Event Reactions associated with medical devices and pharmaceuticals. An adverse event represents a potential public health concern that necessitates continuous documentation, evaluation, and surveillance. Regulatory measures about pharmaceuticals have been enhanced and fortified since the catastrophic sulphanilamide incident of 1937 and the thalidomide tragedy of 1960. In response to these historical events, a Pharmacovigilance System was established, designed to receive, diagnose, assess, monitor, and mitigate the detrimental effects associated with medical products.(1)
The Central Drug Standard Control Organization (CDSCO) oversees the pharmacovigilance framework in India. Within India, the pharmacovigilance initiative is tasked with the oversight of adverse drug responses. India has instituted a comprehensive Pharmacovigilance Program to monitor and document adverse drug reactions. Similarly, the United States has implemented stringent regulations to fortify the pharmacovigilance requirements set forth by the Food & Drug Administration (FDA). The World Health Organization (WHO) has established an International Monitoring System in cooperation with the Uppsala (1–3)Monitoring Centre (UMC).
Improving patient safety and welfare in the Indian population by monitoring drug safety & thereby reducing the risk associated with the use of medicines is the primary mission of the pharmacovigilance program in India. Advocating for safe drug use may become a top focus for the Indian Pharmacopoeia Commission, which also functions as the National Coordination Centre for India's Pharmacovigilance Program. The risk of adverse reactions necessitated the pharmacovigilance system for patient safety. A literature search documented better health literacy of patients through intervention. (3)
KEYWORDS:
Keywords Pharmacovigilance, Adverse Event Reactions, Drug, Drug safety and efficacy, Drug Monitoring
Field Medical / Pharmacy
Published In Volume 7, Issue 1, January-February 2025
Published On 2025-02-07
Cite This Role of Pharmacovigilance Programme of India (PvPI) in Adverse Drug Event Monitoring for medication safety in patient - Aarti, Sanjay Kumar Singh, Mithilesh Kumar - IJFMR Volume 7, Issue 1, January-February 2025. DOI 10.36948/ijfmr.2025.v07i01.36627
DOI https://doi.org/10.36948/ijfmr.2025.v07i01.36627
Short DOI https://doi.org/g84d95
View / Download PDF File

Share this



E-ISSN 2582-2160
CrossRef

CrossRef DOI is assigned to each research paper published in our journal.

IJFMR DOI prefix is
10.36948/ijfmr

Downloads
Research Paper Format Copyright Permission Form and Undertaking Form Cover Page Vol 7 Isu 1Cover Page Vol 6 Isu 6Cover Page Vol 6 Isu 5

All research papers published on this website are licensed under Creative Commons Attribution-ShareAlike 4.0 International License, and all rights belong to their respective authors/researchers.

CC-BY-SA Open Access

About IJFMR
Fees & Payment
Current Issue
Publication Archive 		Submit Research Paper
Track Submission Status
Publication Guidelines
Publication Ethics
Peer Review & Plagiarism 		Join as a Reviewer
Editors & Reviewers
Reviewer Referral Program
Get Reviewer Membership Certi. 		Website/Journal Policies
Usage Policy
Content Policies
Privacy Policy
Contact Us +91-9687-828-838 editor@ijfmr.com